AstraZeneca to build plant in Singapore
Global biopharmaceutical company AstraZeneca intends to build a US$1.5bil manufacturing facility in Singapore, the company says.
Global biopharmaceutical company AstraZeneca intends to build a US$1.5bil manufacturing facility in Singapore, the company says.
Advancecon Holdings Bhd has accepted a letter of acceptance (LoA) from Sime Darby Property (Bukit Jelutong) Sdn Bhd worth RM25.35mil…
As more Vietnamese businesses use international e-Commerce platforms such as Amazon, eBay and Alibaba to expand their market, experts are…
Sunway Healthcare Group has issued its inaugural rated sustainable sukuk amounting to RM400mil for hospital expansion in Malaysia, aiming for…
Microsoft debuted a new category of personal computers (PCs) with artificial intelligence (AI) features as it rushes to build the…
Pos Malaysia Bhd, which posted a smaller net loss in the first quarter ended March 31 (1Q24), remains cautiously optimistic…
PETALING JAYA: Advancecon Holdings Bhd has accepted a letter of acceptance (LoA) from Sime Darby Property (Bukit Jelutong) Sdn Bhd…
KUALA LUMPUR: Tenaga Nasional Bhd (TNB) is preparing for Regulatory Period 4 (RP4) 2025-2027 with significant capital expenditure (capex) to…
KUALA LUMPUR: Iskandar Investment Bhd (IIB) is broadening its collaboration within the Global Business Services (GBS) Iskandar @ Medini initiative,…